Öz
Successful fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography examinations can only be performed in ideal conditions without the interference of drugs. In this letter to editor, we aimed to give brief data about certain drugs which increase FDG uptake.
Anahtar Kelimeler
Fluorodeoxyglucose F18 Positron-emission tomography/computed tomography Drug effects
Kaynakça
- 1. Ayaz S, Durmaz HA, Döğen ME. (2019). Comparison of the FDG PET/CT parameters of primary tumors and liver metastases in cases with gastric adenocarcinomas. Cumhuriyet Üniv Sag Bil Enst Derg; (4)2:25–8.
- 2. Cohade C. Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect. (2010). Semin Nucl Med; 40:283–93.
- 3. Surasi DS, Bhambhvani P, Baldwin JA, Almodovar SE, O'Malley JP. (2014). ¹⁸F-FDG PET and PET/CT patient preparation: a review of the literature. J Nucl Med Technol; 42(1):5−13.
- 4. Baldwin D, Apel J. (2013). Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes. Curr Diab Rep; 13:114–20.
- 5. Sarocchi M, Bauckneht M, Arboscello E, Capitanio S, Marini C, Morbelli S, et al. (2018). An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline. J Transl Med; 16(1):295.
- 6. Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, et al. (2008). High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging; 35(1):95−9.
- 7. Bahler L, Holleman F, Chan MW, Booij J, Hoekstra JB, Verberne HJ. (2017). 18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure. PLoS One; 12(5):e0176242.
- 8. Ozülker T, Ozülker F, Mert M, Ozpaçaci T. (2010). Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging; 37(5):1011−7.
- 9. Oh JR, Song HC, Chong A, Ha JM, Jeong SY, Min JJ, Bom HS. (2010). Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin. AJR Am J Roentgenol; 195(6):1404−10.
- 10. Baba S, Tatsumi M, Ishimori T, Lilien DL, Engles JM, Wahl RL. (2007). Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue. J Nucl Med; 48:981–6.
- 11. Heinen CA, Zhang Z, Klieverik LP, de Wit TC, Poel E, Yaqub M, et al. (2018). Effects of intravenous thyrotropin-releasing hormone on 18F-fluorodeoxyglucose uptake in human brown adipose tissue: a randomized controlled trial. Eur J Endocrinol; 179(1):31−8.
Öz
[18F]-2-floro-2-deoksi-D-glukoz (FDG) pozitron emisyon tomografisi/bilgisayarlı tomografi incelemeleri ancak ilaç etkileşimi olmayan ideal koşullarda gerçekleştirilebilir. Bu editör mektubunda FDG tulumunda artışa yol açan belli ilaçlar hakkında öz bilgi vermeyi amaçladık.
Anahtar Kelimeler
Fluorodeoksiglukoz F18 Pozitron-emisyon tomografi/bilgisayarlı tomografi İlaç etkileri
Kaynakça
- 1. Ayaz S, Durmaz HA, Döğen ME. (2019). Comparison of the FDG PET/CT parameters of primary tumors and liver metastases in cases with gastric adenocarcinomas. Cumhuriyet Üniv Sag Bil Enst Derg; (4)2:25–8.
- 2. Cohade C. Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect. (2010). Semin Nucl Med; 40:283–93.
- 3. Surasi DS, Bhambhvani P, Baldwin JA, Almodovar SE, O'Malley JP. (2014). ¹⁸F-FDG PET and PET/CT patient preparation: a review of the literature. J Nucl Med Technol; 42(1):5−13.
- 4. Baldwin D, Apel J. (2013). Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes. Curr Diab Rep; 13:114–20.
- 5. Sarocchi M, Bauckneht M, Arboscello E, Capitanio S, Marini C, Morbelli S, et al. (2018). An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline. J Transl Med; 16(1):295.
- 6. Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, et al. (2008). High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging; 35(1):95−9.
- 7. Bahler L, Holleman F, Chan MW, Booij J, Hoekstra JB, Verberne HJ. (2017). 18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure. PLoS One; 12(5):e0176242.
- 8. Ozülker T, Ozülker F, Mert M, Ozpaçaci T. (2010). Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging; 37(5):1011−7.
- 9. Oh JR, Song HC, Chong A, Ha JM, Jeong SY, Min JJ, Bom HS. (2010). Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin. AJR Am J Roentgenol; 195(6):1404−10.
- 10. Baba S, Tatsumi M, Ishimori T, Lilien DL, Engles JM, Wahl RL. (2007). Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue. J Nucl Med; 48:981–6.
- 11. Heinen CA, Zhang Z, Klieverik LP, de Wit TC, Poel E, Yaqub M, et al. (2018). Effects of intravenous thyrotropin-releasing hormone on 18F-fluorodeoxyglucose uptake in human brown adipose tissue: a randomized controlled trial. Eur J Endocrinol; 179(1):31−8.
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Konular | Klinik Tıp Bilimleri |
| Bölüm | Editöre Mektup |
| Yazarlar | |
| Yayımlanma Tarihi | 30 Nisan 2020 |
| Yayımlandığı Sayı | Yıl 2020Cilt: 5 Sayı: 1 |
